Primary cerebello-pontine angle melanoma: a case report

Arul TR Ponni, Aniruddha Thekkatte Jagannatha, Janaki Manur Gururajachar, Ritika Harjani, Kirthi AS Koushik, Nirmala Subramanian, Ramani Sowmya, Ravi Gopal Varma


Intra-cranial melanomas are commonly metastatic from primary melanoma elsewhere in the body. The primary occurrence of a melanoma in the brain parenchyma is rare. We report a case of 38 year aged woman who presented with deviation of left eye and headache. On imaging, a space occupying lesion was found in the left Cerebello-pontine angle and a preoperative diagnosis of meningioma was made. She underwent left retro-mastoid sub-occipital craniectomy and excision of a black vascular tumor. Histopathological examination revealed a melanoma which was confirmed with Immunohistochemical assay. Search for dermal, mucous and ocular lesions were negative. She received adjuvant radiation to the post- operative tumor bed to 5400cGy in 30 fractions using Intensity Modulated Radiation Therapy technique along with concurrent Temozolomide. She tolerated the treatment well and is symptom free 12 months after treatment. Primary Melanomas are rare lesions of the Cerebello-pontine angle and its radiological features, evaluation and management have been discussed.


Cite this article as: Ponni A, Jagannatha A, Gururajachar J, Harjani R, Koushik K, Subramanian N, Sowmya R, Varma R. Primary cerebello-pontine angle melanoma: a case report. Int J Cancer Ther Oncol 2014; 2(3):020315. DOI: 10.14319/ijcto.0203.15


Primary Central Nervous System Melanoma; Neurosurgery; Radiotherapy; Temozolomide

Full Text:



Kan P, Shelton C, Townsend J, Jensen R. Primary Malignant Cerebellopontine Angle Melanoma Presenting as a Presumed Meningioma: Case Report and Review of the Literature. Skull Base 2003; 13:159-66.

Bhandari L, Alapatt J, Govindan A, Sreekumar T.Primary cerebellopontine angle melanoma: a case report and review. Turk Neurosurg 2012; 22:469-74.

Shah I, Imran M, Akram R, et al. Primary intracranial malignant melanoma. J Coll Physicians Surg Pak 2013; 23:157-9.

Wadasadawala T, Trivedi S, Gupta T, et al. The diagnostic dilemma of primary central nervous system melanoma. J Clin Neurosci 2010; 17:1014-7.

Larson TC 3rd, Houser OW, Onofrio BM, Piepgras DG. Primary spinal melanoma. J Neurosurg 1987; 66:47-9.

Farrokh D, Fransen P, Faverly D. MR findings of a primary intramedullary malignant melanoma: case report and literature review. AJNR Am J Neuroradiol 2001; 22:1864-6.

Agarwala SS, Kirkwood JM, Gore M, et al. Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 2004; 22:2101-7.

Paul MJ, Summers Y, Calvert AH, et al. Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. Melanoma Res 2002; 12:175-8.

Phang I, Elashaal R, Ironside J, Eljamel S. Primary cerebellopontine angle melanocytoma: review. J NeurolSurg Rep 2012; 73:25-31.

Escott EJ. A variety of appearances of malignant melanoma in the head: a review. Radiographics 2001; 21:625-39.

Hayward RD. Malignant melanoma and the central nervous system. A guide for classification based on the clinical findings. J Neurol Neurosurg Psychiatry 1976; 39:526-30.

Fuster D, Chiang S, Johnson G, et al. Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? J Nucl Med 2004; 45:1323-7.

Belhocine TZ, Scott AM, Even-Sapir E, et al. Role of nuclear medicine in the management of cutaneous malignant melanoma. J Nucl Med 2006; 47:957-67.

Brat DJ, Giannini C, Scheithauer BW, et al. Primary melanocytic neoplasms of the central nervous systems. Am J SurgPathol 1999; 23:745-54.

Dechaphunkul A, Kayasut K, Oearsakul T, et al. Common presentation in an uncommon disease: case report of a patient with primary diffuse leptomeningealmelanocytosis. J Clin Oncol 2011; 29:e816-8.

Rodriguez y Baena R, Gaetani P, Danova M, et al. Primary solitary intracranial melanoma: case report and review of the literature. Surg Neurol 1992; 38:26-37.


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.


International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the '' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.


Number of visits since October, 2013